These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11960325)

  • 1. Identification of novel targets for cancer therapy using expression proteomics.
    Hanash SM; Madoz-Gurpide J; Misek DE
    Leukemia; 2002 Apr; 16(4):478-85. PubMed ID: 11960325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global profiling of gene expression in cancer using genomics and proteomics.
    Hanash SM
    Curr Opin Mol Ther; 2001 Dec; 3(6):538-45. PubMed ID: 11804268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and proteomic technologies for individualisation and improvement of cancer treatment.
    Wulfkuhle J; Espina V; Liotta L; Petricoin E
    Eur J Cancer; 2004 Nov; 40(17):2623-32. PubMed ID: 15541963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling predicts drug response to novel targeted anticancer therapeutics.
    Lin F; Li Z; Hua Y; Lim YP
    Expert Rev Proteomics; 2016; 13(4):411-20. PubMed ID: 26954459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics and the analysis of proteomic data: an overview of current protein-profiling technologies.
    Gulcicek EE; Colangelo CM; McMurray W; Stone K; Williams K; Wu T; Zhao H; Spratt H; Kurosky A; Wu B
    Curr Protoc Bioinformatics; 2005 Jul; Chapter 13():Unit 13.1. PubMed ID: 18428746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease proteomics.
    Hanash S
    Nature; 2003 Mar; 422(6928):226-32. PubMed ID: 12634796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulfilling the promise: drug discovery in the post-genomic era.
    Chanda SK; Caldwell JS
    Drug Discov Today; 2003 Feb; 8(4):168-74. PubMed ID: 12581711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics approaches for myeloid leukemia drug discovery.
    Kapoor I; Pal P; Lochab S; Kanaujiya JK; Trivedi AK
    Expert Opin Drug Discov; 2012 Dec; 7(12):1165-75. PubMed ID: 22971110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics for hepatocellular carcinoma marker discovery.
    Chignard N; Beretta L
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S120-5. PubMed ID: 15508075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane proteomics for leukemia classification and drug target identification.
    Kohnke PL; Mulligan SP; Christopherson RI
    Curr Opin Mol Ther; 2009 Dec; 11(6):603-10. PubMed ID: 20072937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics-based anticancer drug discovery and development.
    Jain KK
    Technol Cancer Res Treat; 2002 Aug; 1(4):231-6. PubMed ID: 12625781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a comprehensive understanding of Bacillus subtilis cell physiology by physiological proteomics.
    Hecker M; Völker U
    Proteomics; 2004 Dec; 4(12):3727-50. PubMed ID: 15540212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics of the heart: unraveling disease.
    McGregor E; Dunn MJ
    Circ Res; 2006 Feb; 98(3):309-21. PubMed ID: 16484627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics.
    Celis JE; Kruhøffer M; Gromova I; Frederiksen C; Ostergaard M; Thykjaer T; Gromov P; Yu J; Pálsdóttir H; Magnusson N; Orntoft TF
    FEBS Lett; 2000 Aug; 480(1):2-16. PubMed ID: 10967322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK; Busch CM; Felix CA; Blair IA
    J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of proteomic technologies to tumor analysis.
    Misek DE; Imafuku Y; Hanash SM
    Pharmacogenomics; 2004 Dec; 5(8):1129-37. PubMed ID: 15584879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical strategies for functional proteomics.
    Adam GC; Sorensen EJ; Cravatt BF
    Mol Cell Proteomics; 2002 Oct; 1(10):781-90. PubMed ID: 12438561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
    Manes NP; Nita-Lazar A
    J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics in postgenomic neuroscience: the end of the beginning.
    Choudhary J; Grant SG
    Nat Neurosci; 2004 May; 7(5):440-5. PubMed ID: 15114355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technologies for the study of gene and protein expression in Plasmodium.
    Carucci DJ
    Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):13-6. PubMed ID: 11839177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.